Healthcare, Life Sciences and Pharmaceuticals · Published Aug 2026
Healthcare Asset Management Market
The global healthcare asset management market is projected to expand from USD 10.0 billion in 2025 to USD 18.77 billion by 2035, reflecting a compound annual growth rate (CAGR) of 6.5%. This growth trajectory is underpinned by increasing healthcare expenditures, rising demand for operational efficiency, and the integration of advanced technologies such as AI, IoT, and RFID. The market encompasses solutions for equipment, machinery, and physical assets, including pumps, HVAC systems, wheelchairs, and refrigeration units, enabling faster asset location, optimized inventory, and improved staff communication.
North America currently leads the market, while Asia-Pacific is anticipated to exhibit the fastest growth over the forecast period.
Market size
Growth trajectory through 2035
Healthcare Asset Management Market · Market size 2025–2035
Base year 2025 · Forecast 2035 · USD Billion
Source: Exactitude Consultancy analyst modeling. Anchor values from primary + secondary research; intermediate years interpolated from the CAGR trajectory. Full annual data pack included with the report.
What's new in this edition
Here's what changed
This edition rebased the forecast to 2025, added tracked developments through the last quarter, and re-cited every numeric claim against live public sources.
Recent developments tracked
-
Development 01 Technological Innovations
- Advances in RFID and RTLS technologies have enabled more accurate and real-time asset tracking, improving operational efficiency in healthcare facilities.
-
Development 02 Regulatory Updates
- Compliance with new regulations, such as the FDA’s DSCSA and the European FMD, has driven the adoption of RFID-enabled refrigeration systems for pharmaceutical storage, ensuring traceability and security.
-
Development 03 Strategic Partnerships
- Collaborations between healthcare providers and technology vendors have led to the development of integrated asset management solutions, combining hardware, software, and analytics to address specific healthcare challenges.
-
Development 04 Market Expansion
- Companies are expanding their presence in emerging markets, leveraging the growing demand for asset management solutions in regions with rapidly developing healthcare infrastructure.
Emerging opportunities added
- Expansion in Developing Markets Rapidly growing healthcare infrastructure in regions such as Asia-Pacific and Latin America presents significant opportunities for market expansion, driven by increasing healthcare investments and the adoption of advanced asset management technologies.
- Integration with Predictive Analytics Leveraging predictive analytics to forecast equipment maintenance needs and optimize asset utilization can enhance operational efficiency and reduce downtime in healthcare facilities.
- Smart Building and IoT Integration The convergence of asset management with smart building technologies and IoT-enabled devices can provide real-time insights into asset performance, enabling proactive maintenance and energy efficiency.
- Collaborations and Partnerships Strategic collaborations between healthcare providers, technology vendors, and regulatory bodies can accelerate innovation and adoption of asset management solutions tailored to specific healthcare needs.
Executive snapshot
The four things that matter
A condensed view of the market at a glance — sized, shaped, and pressure-tested against live public sources.
Market size · 2025–2035
forecast for 2035
- 2025 base
- $10.00 Bn
- CAGR
- 6.50%
- Expansion
- 1.9×
Market shape
top segment · 100.0% share
- Leading region
- North America
- Top-5 concentration
- Low to medium · ~42%
Forces at play
▲ top tailwind
- ▼ headwind
- High Implementation Costs
- Named players
- 15 profiled
- Growth peak
- 2027–2031
Latest development
Technological Innovations: Advances in RFID and RTLS technologies have enabled more accurate and real-time asset tracking, improving operational efficiency in healthcare facilities
+3 more tracked in this edition
Report scope
What this report answers
The specific decisions and questions covered in the 68-page report and its accompanying data pack — tailored to this market's segments, applications, and named competitors.
- How big is the Healthcare Asset Management Market today ($10.00 Bn base), and how fast will it grow at 6.5% CAGR through 2035?
- Which of hardware solutions for asset tracking, management holds the largest share, and how do the growth rates diverge?
- How do North America, Europe, Asia-Pacific, Latin America, and MEA compare on market share and growth rate?
- Where do Epic Systems Corporation, Oracle Health (Cerner), Veeva Systems and 12 other named players sit in market share, tier, and product breadth?
- What are the top growth drivers (led by Technological Advancements) and top restraints (led by High Implementation Costs), with quantified CAGR impact?
- What regulatory shifts and 4 tracked developments (2024–2025) materially affect the forecast?
- Which segments and geographies present the strongest investment thesis given the growth-window 2027–2031?
Market dynamics
Why the number moves this way
The forces expanding this market and the ones holding it back — each broken down into distinct, scannable points.
Growth drivers
Pulling the market up
- Technological Advancements Integration of AI, IoT, and RFID technologies is modernizing traditional asset management procedures, enabling real-time tracking, automated inventory management, and improved operational visibility in healthcare facilities.
- Rising Healthcare Expenditures Increasing investments in healthcare infrastructure and the need for cost-effective asset management solutions are driving market growth.
- Regulatory Compliance and Drug Counterfeiting Stringent regulatory frameworks and the need to combat drug counterfeiting are propelling the adoption of advanced asset management systems, particularly in pharmaceutical storage and supply chain management.
- Operational Efficiency Asset management solutions help healthcare providers reduce costs, improve asset utilization, and enhance staff productivity by streamlining equipment tracking and inventory management.
Restraints
Holding it back
- High Implementation Costs The initial capital expenditure required for deploying advanced asset management systems, including RFID and RTLS technologies, may pose a barrier to adoption, particularly for smaller healthcare providers.
- Data Security and Privacy Concerns The integration of IoT and cloud-based solutions introduces vulnerabilities related to data breaches and unauthorized access, necessitating robust cybersecurity measures.
- Regulatory Hurdles Compliance with evolving healthcare regulations, such as the FDA’s Drug Supply Chain Security Act (DSCSA) and the European Falsified Medicines Directive (FMD), may delay the adoption of certain asset management solutions.
- Interoperability Challenges The lack of standardized protocols for integrating asset management systems with existing healthcare IT infrastructure can hinder seamless adoption and scalability.
Trends
What we're watching
- Consolidation activity is accelerating as top players seek scale advantages; the report tracks named M&A + partnerships quarterly.
- Sustainability and traceability requirements are reshaping procurement criteria across enterprise buyers.
Impact analysis
Quantified drivers & restraints
Percentages are directional contributions to overall CAGR — not additive. Full sensitivity tables in the sample.
| Driver | % Impact on CAGR | Geographic Relevance | Impact Timeline |
|---|---|---|---|
| Technological Advancements | +2.9% | Global | 2025–2035 |
| Rising Healthcare Expenditures | +1.8% | Global | 2025–2035 |
| Regulatory Compliance and Drug Counterfeiting | +1.4% | Global | 2025–2035 |
| Operational Efficiency | +1.0% | Global | 2025–2035 |
Restraints impact analysis
| Restraint | % Impact on CAGR | Geographic Relevance | Impact Timeline |
|---|---|---|---|
| High Implementation Costs | −1.2% | Global | 2025–2029 |
| Data Security and Privacy Concerns | −0.8% | Global | 2025–2029 |
| Regulatory Hurdles | −0.6% | Global | 2025–2029 |
Total 6 Radiofrequency I 50% Real-time Locati 33% Others 17% The healthcare asset management market is segmented by product type, application, and end use:
Revenue share by type · 2025 base year
% OF $10.00 BN HEALTHCARE ASSET MANAGEMENT MARKET · 1 TYPES COVERED
Each slice = that type's share of the total $10.00 Bn Healthcare Asset Management Market in 2025. Shares sum to 100%. Per-segment historicals + 2035 forecasts are in the report data pack.
By type
-
hardware solutions for asset tracking
-
management
Geography
Regional market share
Base-year (2025) share by region. Growth rates through 2035 vary widely by market maturity — country-level detail sits in the report.
Regional share · 2025
SHARE OF $10.00 BN BASE MARKET
Bars sized to relative regional share. Leader region highlighted in gold.
North America leads regional demand at ~46.6% in 2025. Driven by manufacturing scale and end-market density.
Competitive landscape
Who's competing, and how
The market is Low to Medium concentration. 15 named players are profiled in the report with product portfolios, financials where public, and recent strategic moves.
The healthcare asset management market is characterized by the presence of established players and emerging technology providers. Key companies such as Pfizer, Johnson & Johnson, Merck, Novartis, Roche, AbbVie, Eli Lilly, AstraZeneca, GSK, and GlaxoSmithKline are actively engaged in developing and deploying asset management solutions tailored to the healthcare sector. Competition is driven by innovation in RFID, RTLS, and IoT technologies, as well as strategic partnerships to enhance product offerings and market reach.
Concentration snapshot
Top 5 players control ~35–50% of the market
Estimated aggregate share of the top 5 by 2025 revenue. Named breakdown + individual shares in the full report.
Competitive tiers
Players are grouped into three tiers by revenue rank, product breadth, and strategic footprint. Full tier assignment in the report.
Tier 1 · Leaders
3companies
Global scale, integrated portfolio, brand recognition. Setting the pricing benchmark.
Tier 2 · Challengers
5companies
Regional strongholds, focused portfolio, actively expanding via M&A or capacity.
Tier 3 · Emerging
7companies
Niche or early-stage, differentiated technology or early-mover positioning.
Named players covered
Every profiled company includes market rank, base-year share, revenue estimate, HQ, product portfolio depth, and recent strategic moves. Unlock in the sample.
-
Epic Systems Corporation
Rank 01Share est. ~16%Revenue $■■■MHQ ■■■ -
Oracle Health (Cerner)
Rank 02Share ■■.■%Revenue $■■■MHQ ■■■ -
Veeva Systems
Rank 03Share ■■.■%Revenue $■■■MHQ ■■■ -
IQVIA Holdings
Rank 04Share ■■.■%Revenue $■■■MHQ ■■■ -
Waystar Holding
Rank 05Share ■■.■%Revenue $■■■MHQ ■■■ -
Veradigm Inc
Rank 06Share ■■.■%Revenue $■■■MHQ ■■■ -
athenahealth Inc
Rank 07Share ■■.■%Revenue $■■■MHQ ■■■ -
Teladoc Health
Rank 08Share ■■.■%Revenue $■■■MHQ ■■■
+ 7 more player profiles in the full report.
Unlock the full competitive landscape
Per-player market share, revenue estimates, HQ, product portfolio depth, recent M&A + partnerships, and 3-tier ranking rationale — sample included.
Regulatory landscape
Policy and standards affecting the forecast
Material regulatory shifts across the major regional markets. The report tracks these quarter-by-quarter and quantifies their forecast impact.
-
United States
FDA CDER/CBER approves new drugs and biologics; typical NDA review 10 months (standard), 6 months (priority). IRA drug price negotiation covers first 10 Medicare Part D drugs 2026, expanding annually. CMS coverage decisions gate market access. State-level PBM reform + 340B changes reshape distribution.
-
European Union
EMA centralised procedure mandatory for biotech, oncology, HIV, orphan drugs — 210-day evaluation timeline. HTA Regulation (EU 2021/2282) unifies clinical assessment across member states from 2025. Joint clinical assessment for cancer + advanced therapies 2025, orphans 2028. GDPR + national health data laws govern secondary use of clinical data.
-
China / APAC
NMPA reform since 2015 reduced approval times from 5+ years to ~14 months; ICH-aligned data acceptance. Volume-based procurement (VBP) rounds 1-11 have negotiated pricing for 500+ drugs (avg 50-80% reduction). National Reimbursement Drug List (NRDL) annual negotiation determines Chinese market access.
-
Global standards
ICH (International Council for Harmonisation) guidelines adopted by FDA, EMA, PMDA, NMPA, Health Canada, and Swissmedic. WHO Prequalification enables procurement by UN agencies and major donors. USP, EP, JP pharmacopoeia standards govern drug quality worldwide. GxP quality standards (GCP, GMP, GLP, GVP) universal.
Purchase options
License this report
All licenses include the full PDF report + Excel data pack + one analyst clarification call. Choose based on how many colleagues will need access.
Single user
$3,499
- 1 named user, non-transferable
- Full PDF + Excel data pack
- 1 hour analyst clarification call
Multi user
$4,499
- Up to 5 users at one location
- Full PDF + Excel data pack
- 2 hours analyst time
- Priority email support
Corporate
$5,499
- Unlimited users org-wide
- Full PDF + Excel data pack
- 4 hours analyst time
- Presentation-ready deck
Need custom scope, region cuts, or country-level detail? Request customization or speak to an analyst.
How buying works
- 01 Select a license — your enquiry reaches the desk lead within one business day.
- 02 Invoice issued — pay by wire transfer, corporate PO, or online (PayPal / Razorpay / cards). Preferred by most procurement teams.
- 03 Report delivered — full PDF + Excel data pack + analyst call slot in your inbox on receipt of payment.
Payment methods accepted
- PayPalGlobal
- RazorpayCards · UPI · Netbanking
- Visa · Mastercard · AmexVia gateway
- Wire transferUSD · EUR · INR · GBP
- Corporate PONet-30 on approval
Invoices raised in your billing currency. Enterprise procurement docs (W-9 / W-8BEN / VAT registration) available on request.
Methodology
How we built this estimate
Every number in this report is derived from three converging paths — primary interviews, top-down macro sizing, and bottom-up named-company revenue build-up — and re-verified against live public sources at each edition refresh.
-
Primary research
Structured analyst interviews with buyers, vendors, and distributors across the value chain — top-tier OEMs, mid-market integrators, and specialised suppliers. Respondent distribution is disclosed in the sample so readers can weight the mix themselves.
-
Secondary research
Company filings, trade association reports, government statistics, and paid databases feed the top-down macro layer. Every source is footnoted in the report so any downstream reader can retrace how a number was arrived at.
-
Data triangulation
Three independent estimation paths — top-down macro sizing, bottom-up named-company build-up, and cross-check against installed-base or shipment proxies — converge to a single defensible number. Divergences greater than 8% trigger a re-review.
-
Analyst review
Every model is pressure-tested by a senior analyst before publication. Assumptions are stated explicitly, sensitivities are documented, and the accompanying Excel data pack lets clients replicate every calculation on their own inputs.
Frequently asked questions
Common questions about this report
-
• What is the worth of global Healthcare Asset Management market?
The healthcare asset management market reached USD 6.48 billion in 2020 and is expected to grow at a CAGR of more than 29.7% through 2029, owing to the increasing in awareness about health. -
• What are the upcoming trends of healthcare asset management market, globally?
The upcoming trend in the healthcare asset management market is an opportunity for market growth. -
• What is the CAGR of healthcare asset management market?
The global healthcare asset management market registered a CAGR of 29.7% from 2022 to 2029. -
• Which are the top companies to hold the market share in healthcare asset management market?
Key players profiled in the report include Healthcare Stanley Black & Decker, Inc., Airista Flow, Centrak, GE Healthcare, IBM, Elpas, Sonitor, Versus Technology, Intelligent Insites, and Thingmagic. -
• Which is the largest regional market for healthcare asset management market?
The North America healthcare asset management market had largest market share of 48% in 2021.
The Healthcare Asset Management Market is projected to reach $18.77 Bn by 2035, up from $10.00 Bn in 2025 — a 6.50% CAGR equating to roughly 1.9× expansion. The bars anchor both endpoints so you can pressure-test the trajectory against your own assumptions.